Маркери запалення та функції ендотелію у хворих на ішемічну хворобу серця (огляд літератури)

E. H. Zaremba; O. V. Smaliukh

doi:10.24061/2413-0737.XVIII.4.72.2014.226

Автор(и)

E. H. Zaremba
O. V. Smaliukh

DOI:

https://doi.org/10.24061/2413-0737.XVIII.4.72.2014.226

Ключові слова:

ішемічна хвороба серця, ендотелій, С-реактивний протеїн, цитокіни, ендотелін-1

Анотація

У статті представлено сучасні дані про маркери функції ендотелію та запалення, їх значення при ішемічній хворобі серця.

Посилання

Bilovol OM, Kravchun PH. Aktyvnist' faktora nekrozu pukhlyn-α ta interleykinu-6 v syrovattsi krovi u khvorykh na ishemichnu khvorobu sertsya ta tsukrovyy diabet 2-ho typu [Activity of tumor necrosis factor-α and Interleukin-6 inserum of patients with ischemic stroke heart disease and type 2 diabetes]. Liky Ukrayiny. 2010;8:101-3. (in Ukrainian).

Bogova OT, Chukareva II. Infarkt miokarda. Vospalenie i prognoz [Myocardial infarction. Inflammation and prognosis]. Ros. kardiol. zh. 2003;4:95-7. (in Russian).

Vatutin NT, Kalinkina NV, Demidova AL. Endoteliny i serdechno-sosudistaya patologiya [Endothelins and cardiovascular pathology]. Ukr. kardiol. zh. 2006;1:101-6. (in Russian).

Henyk SM. Endotelial'na dysfunktsiya v patofiziolohiyi porushen' pry khronichniy venozniy nedostatnosti ta mozhlyvosti yiyi korektsiyi mikronizovanym diosminom [Endothelial dysfunction in pathophysiology disorders with chronic venous insufficiency and possibility of its correction by micronized diosmin]. Sertse i sudyny. 2009;3:99-103. (in Ukrainian).

Golovchenko YuI, Treshchins'ka MA. Obzor sovremennykh predstavleniy ob endotelial'noy disfunktsii [Overview of modern views about endothelial dysfunction]. Consilium Medicum. 2008;11:38-40. (in Russian).

Dunayeva IP. Osoblyvosti protyzapal'noyi tsytokinovoyi lanky u khvorykh na ishemichnu khvorobu sertsya ta tsukrovyy diabet 2-ho typu [Features of anti-inflammatory cytokine links to patients with coronary heart disease and type 2 diabetes mellitus]. Probl. endokrin. 2013;2:28-32. (in Ukrainian).

Zykov MV, Barbarash OL, Karetnikova VN, Kashtalan VV. Ispol'zovanie biomarkerov – tsitokinov v diagnostike i prognozirovanii techeniya infarkta miokarda [The use of biomarkers - cytokines in the diagnosis and prediction of the course of myocardial infarction]. Kemerovo; 2012. 7-16 р. (in Russian).

Zaremba YeKh, Kyyak YuH, Babynina LYa. Kardiolohiya dlya simeynykh likariv [Cardiology for family doctors]. Kiev: Polihrafist; 2011. 532 р. (in Ukrainian).

Katunina OR, Rezaykina AV. Provospalitel'nye tsitokiny IL-1 i FNO-al'fa v ochagakh porazhennoy kozhi bol'nykh psoriazom [Proinflammatory cytokines IL-1 and TNF-alpha in the foci of affected skin of psoriasis patients]. Vestn. dermatol. i venerol. 2011;4:25-30. (in Russian).

Kovalenko VM, Kornats'kyy VM. Rehional'ni medyko-sotsial'ni problemy khvorob systemy krovoobihu. Dynamika ta analiz [Regional medical and social problems of circulatory system diseases. Dynamics and analysis]. Kiev; 2013. 69 р. (in Ukrainian).

Kondashevskaya MV. Sovremennye predstavleniya o roli geparina v gemostaze i regulyatsii fermentativnoy i gormonal'noy aktivnosti (obzor literatury) [Modern ideas about role of heparin in hemostasis and regulation of enzymatic and hormonal activity (literature review)]. Vestn. RAMN. 2010;7:35-43. (in Russian).

Kravchun PH, Shelest MO, Koval'ova YuO. Osoblyvosti zmin markeriv zapalennya u khvorykh na ishemichnu khvorobu sertsya z ozhyrinnyam [Features of changes of markers of inflammation in patients with ischemic heart disease with obesity]. Med. s'ohodni i zavtra. 2013;2:38-42. (in Ukrainian).

Lomakovs'kyy OM. Vplyv statyniv na pokaznyky imunnoho zapalennya, lipidnoho spektra krovi, perekysnoho okysnennya lipidiv ta bilkiv u khvorykh na khronichnu ishemichnu khvorobu sertsya [Effect of statins on metrics immune inflammation, lipid blood spectrum, peroxidation of lipids and proteins in patients with chronic ischemic heart disease]. Ukr. kardiol. zh. 2010;4:41-8. (in Ukrainian).

Lutay MI. Ateroskleroz: sovremennyy vzglyad na patogenez [Atherosclerosis: a modern look at pathogenesis]. Ukr. kardiol. zh. 2004;1:22-4. (in Russian).

Lutay MI, Golikova IP, Slobodskoy VA. Rol' disfunktsii endoteliya, vospaleniya i dislipidemii v aterogeneze [The role of endothelial dysfunction, inflammation and dyslipidemia in atherogenesis]. Ukr. kardiol. zh. 2007;5:37-7. (in Russian).

Milyutina OV, Chicherina EN. Prognosticheskaya rol' S-reaktivnogo belka v razvitii riska kardial'nykh sobytiy [The role of endothelial dysfunction, inflammation and dyslipidemia in atherogenesis]. Ros. kardiol. zh. 2011;1:71-3. (in Russian).

Kovalenko VM, editor. Nastanova z kardiolohiyi [Cardiology Guide]. Kiev: MORION; 2009. 1368 р. (in Ukrainian).

Tereshkevych LP, Shumakov VO, Malynovs'ka IE. Osoblyvosti endotelial'noyi funktsiyi v khvorykh u ranniy pislyainfarktnyy period na tli terapiyi peryndoprylom [Features of endothelial function in patients in the early post-infarction period on the background of perindopril therapy]. Ukr. kardiol. zhurnal. 2008;5:44-8. (in Ukrainian).

Alifirova VM, Orlova YuYu, Titova MA. Polimorfizm gena interleykina-1 (IL-1β) u bol'nykh rasseyannym sklerozom [Polymorphism of the interleukin-1 (IL-1β) gene in patients with multiple sclerosis]. Nevrolog. vestnik. 2010;42(1):23-7. (in Russian).

Peremot SD, Smilyans'ka MV. Polifokal'nist' ushkodzhen' koronarnoho rusla ta dysbalans rivniv tsytokiniv u khvorykh z koronarnym aterosklerozom [Polyphobia of damages of the coronary bed and imbalance of cytokine levels in patients with coronary heart disease atherosclerosis]. Annals of Mechnikov Institute. 2012;4:158-61. (in Ukrainian).

Popkova TV, Novikova DS, Nasonov EL. Іnterleykin-6 i serdechno-sosudistaya patologiya pri revmatoidnom artrite [Interleukin-6 and cardiovascular pathology in rheumatoid arthritis]. Nauch.-prakt. revmatol. 2011;4:64-2. (in Russian).

Prystupa LN, Hrek AV, Ataman YuO. Klinichne znachennya homotsysteyinemiyi v aterosklerotychnomu protsesi (ohlyad literatury) [Clinical significance of homocysteineemia in atherosclerotic process (literature review)]. Visn. SumDU. Seriya «Medytsyna». 2012;1:54-61. (in Ukrainian).

Libov IA, Kiselev MV, Smirnova VYu. Prognosticheskaya rol' endotelina-1 i vozmozhnosti ego korrektsii u bol'nykh s nestabil'noy stenokardiey [Prognostic role of endothelin-1 and the possibility of its correction in patients with unstable angina]. Rus. med. zh. 2008;16(1):31-3. (in Russian).

Ershova OB, Belova KYu, Novikova IV. Rol' tsitokinov v razvitii serdechno-sosudistykh zabolevaniy i osteoporoza (obzor literatury) [The role of cytokines in the development of cardiovascular diseases and osteoporosis (literature review)]. Osteoporoz i osteopatii. 2011;3:33-5. (in Russian).

Skybchyk VA. Insulinorezystentnist' ta systemne zapalennya u khvorykh na hostryy infarkt miokarda i tsukrovyy diabet 2-ho typu: klinichne znachennya [Insulin resistance and systemic inflammation in patients with acute myocardial infarction and Type 2 diabetes: Clinical significance]. Ukr. med. chasopys. 2007;2:72-7. (in Ukrainian).

Novikova DS, Bekbosynova MS, Loladze NV. S-reaktivnyy belok i interleykin-6 u bol'nykh s zheludochkovymi narusheniyami ritma serdtsa: vozmozhnaya rol' vospaleniya v razvitii zheludochkovykh aritmiy [C-reactive protein and interleukin-6 inpatients with ventricular arrhythmias: the possible role of inflammation in the development of ventricular arrhythmias]. Kardiologiya. 2004;5:63-6. (in Russian).

Dzyak HV, Bil'chenko OV. Taktyka simeynoho likarya u vedenni khvorykh z naybil'sh poshyrenymy sertsevo-sudynnymy zakhvoryuvannyamy [Tactics of a family doctor in the management of patients with the most widespread cardiovascular disease]. Kiev: Medical Cards; 2012. 88 р. (in Ukrainian).

Freydlin IS. Immunnaya sistema i ee defekty [The immune system and its defects]. St. Petersburg; 1998. 113р. (in Russian).

Havrylenko TI, Slobods'kyy TA, Kornilina OM. Tsytokinprodukuyucha vlastyvist' mononuklearnykh klityn ta riven' endotelinu v plazmi krovi u khvorykh na stabil'nu stenokardiyu napruzhennya [The cytokine producing property of mononuclear cells and the level of endothelin in blood plasma in patients with stable angina pectoris]. Ukr. med. chasopys. 2012;2:134-36. (in Ukrainian).

Shevchenko OP, Slesareva YuS, Shevchenko AO. Sravnitel'nyy analiz urovnya proteina plazmy i drugikh markerov vospaleniya v krovi u bol'nykh s ostrym koronarnym sindromom [Comparative analysis of the level of plasma protein and other markers of inflammation in the blood in patients with acute coronary syndrome]. Ros. kardiol. zh. 2008;6:45-50. (in Russian).

Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-15.

Cook NR, Ridker PM, Buring JE. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann. Intern. Med. 2006;145:21-9.

Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(15):27-32.

Dhaun N, Gorrad J, Webb DJ. The Endothelin System and Its Antagonism in Chronic Kidney Disease. J. Am. Soc. Nephrol. 2006;17:943-55.

Biasucci LM, Vitelli A, Liuzzo G. Elevated levels of interleukin-6 inunstable angina. Circulation. 1996;94:874-77.

Nalbandian A, Crispín JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clinical and Experimental Immunology. 2009;157:209-15.

Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int. J. Endocrinol. 2013;2013:11. Available from: http://www.hindawi.com/journals/ije/2013/678159/.

Paoletti R, Gotto AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004;109:20-6.

Ridker PM, Cushman M, Stampfer MJ. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97(10):425-28.

Waterer GW, Wunderink RG. Science review: Genetic variability in the systemic inflammatory response. Critical Care. 2003;7:308-14.